Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 2,000 shares, a drop of 59.2% from the August 31st total of 4,900 shares. Based on an average trading volume of 470,000 shares, the days-to-cover ratio is presently 0.0 days.
Oncotelic Therapeutics Stock Performance
Oncotelic Therapeutics stock opened at $0.02 on Friday. Oncotelic Therapeutics has a one year low of $0.02 and a one year high of $0.05. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.01 and a quick ratio of 0.01. The business has a fifty day moving average of $0.02 and a two-hundred day moving average of $0.03.
Oncotelic Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Oncotelic Therapeutics
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Stock Analyst Ratings and Canadian Analyst Ratings
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Oncotelic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncotelic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.